Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008–2015
, Qiaohong Liao1
, Mong How Ooi, Benjamin J. Cowling, Zhaorui Chang, Peng Wu, Fengfeng Liu, Yu Li, Li Luo, Shuanbao Yu, Hongjie Yu2
, and Sheng Wei2
Author affiliations: Huazhong University of Science and Technology, Wuhan, China (J. Huang, S. Wei); Chinese Center for Disease Control and Prevention, Beijing, China (J. Huang, Q. Liao, Z. Chang, F. Liu, Y. Li, L. Luo, S. Yu, H. Yu); Sarawak General Hospital, Kuching, Malaysia (M.H. Ooi); Universiti Malaysia Sarawak, Kota Samarahan, Malaysia (M.H. Ooi); The University of Hong Kong, Hong Kong, China (B.J. Cowling, P. Wu, Y. Li); Fudan University, Shanghai, China (H. Yu)
Figure 3. Geographic distribution of patients with recurrent HFMD (A) and episodes of enterovirus infection (B) in 29 provinces of China, 2008–2015. A) Pie charts correspond to the number of recurrent laboratory-confirmed HFMD cases. B) Pie charts correspond to the number of laboratory-confirmed HFMD episodes. CV-A16, coxsackievirus A16; EV-A71, enterovirus A71; HFMD, hand, foot and mouth disease; other EVs, non–EV-A71 and non–CV-A16 enteroviruses.
Page created: February 12, 2018
Page updated: February 12, 2018
Page reviewed: February 12, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.